Axogen Statistics
Total Valuation
Axogen has a market cap or net worth of $826.39 million. The enterprise value is $876.39 million.
Important Dates
The next confirmed earnings date is Wednesday, October 29, 2025, before market open.
| Earnings Date | Oct 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Axogen has 46.01 million shares outstanding. The number of shares has increased by 4.78% in one year.
| Current Share Class | 46.01M |
| Shares Outstanding | 46.01M |
| Shares Change (YoY) | +4.78% |
| Shares Change (QoQ) | +6.14% |
| Owned by Insiders (%) | 1.64% |
| Owned by Institutions (%) | 88.22% |
| Float | 45.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 779.83 |
| PS Ratio | 4.05 |
| Forward PS | 3.48 |
| PB Ratio | 7.41 |
| P/TBV Ratio | 7.88 |
| P/FCF Ratio | 169.17 |
| P/OCF Ratio | 116.33 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 101.33, with an EV/FCF ratio of 177.34.
| EV / Earnings | n/a |
| EV / Sales | 4.31 |
| EV / EBITDA | 101.33 |
| EV / EBIT | 511.91 |
| EV / FCF | 177.34 |
Financial Position
The company has a current ratio of 4.14, with a Debt / Equity ratio of 0.63.
| Current Ratio | 4.14 |
| Quick Ratio | 2.32 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | 5.57 |
| Debt / FCF | 14.22 |
| Interest Coverage | 0.22 |
Financial Efficiency
Return on equity (ROE) is -4.48% and return on invested capital (ROIC) is 0.61%.
| Return on Equity (ROE) | -4.48% |
| Return on Assets (ROA) | 0.54% |
| Return on Invested Capital (ROIC) | 0.61% |
| Return on Capital Employed (ROCE) | 0.95% |
| Revenue Per Employee | $449,715 |
| Profits Per Employee | -$10,316 |
| Employee Count | 452 |
| Asset Turnover | 1.03 |
| Inventory Turnover | 1.61 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.49% in the last 52 weeks. The beta is 1.04, so Axogen's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | +38.49% |
| 50-Day Moving Average | 16.60 |
| 200-Day Moving Average | 15.34 |
| Relative Strength Index (RSI) | 64.69 |
| Average Volume (20 Days) | 792,986 |
Short Selling Information
The latest short interest is 2.48 million, so 5.40% of the outstanding shares have been sold short.
| Short Interest | 2.48M |
| Short Previous Month | 2.11M |
| Short % of Shares Out | 5.40% |
| Short % of Float | 5.49% |
| Short Ratio (days to cover) | 2.84 |
Income Statement
In the last 12 months, Axogen had revenue of $203.27 million and -$4.66 million in losses. Loss per share was -$0.10.
| Revenue | 203.27M |
| Gross Profit | 150.96M |
| Operating Income | 1.71M |
| Pretax Income | -4.66M |
| Net Income | -4.66M |
| EBITDA | 8.65M |
| EBIT | 1.71M |
| Loss Per Share | -$0.10 |
Full Income StatementBalance Sheet
The company has $29.92 million in cash and $70.27 million in debt, giving a net cash position of -$40.34 million or -$0.88 per share.
| Cash & Cash Equivalents | 29.92M |
| Total Debt | 70.27M |
| Net Cash | -40.34M |
| Net Cash Per Share | -$0.88 |
| Equity (Book Value) | 112.28M |
| Book Value Per Share | 2.45 |
| Working Capital | 78.44M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $7.19 million and capital expenditures -$2.25 million, giving a free cash flow of $4.94 million.
| Operating Cash Flow | 7.19M |
| Capital Expenditures | -2.25M |
| Free Cash Flow | 4.94M |
| FCF Per Share | $0.11 |
Full Cash Flow StatementMargins
Gross margin is 74.27%, with operating and profit margins of 0.84% and -2.29%.
| Gross Margin | 74.27% |
| Operating Margin | 0.84% |
| Pretax Margin | -2.29% |
| Profit Margin | -2.29% |
| EBITDA Margin | 4.25% |
| EBIT Margin | 0.84% |
| FCF Margin | 2.43% |
Dividends & Yields
Axogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.78% |
| Shareholder Yield | -4.78% |
| Earnings Yield | -0.56% |
| FCF Yield | 0.59% |
Dividend DetailsAnalyst Forecast
The average price target for Axogen is $25.83, which is 43.82% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.83 |
| Price Target Difference | 43.82% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 16.59% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Axogen has an Altman Z-Score of 3.47 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.47 |
| Piotroski F-Score | 5 |
